These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9207800)

  • 21. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment.
    Franceschi RT
    Crit Rev Oral Biol Med; 1999; 10(1):40-57. PubMed ID: 10759426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype-phenotype correlations.
    Yoshida T; Kanegane H; Osato M; Yanagida M; Miyawaki T; Ito Y; Shigesada K
    Blood Cells Mol Dis; 2003; 30(2):184-93. PubMed ID: 12732182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RUNX2 mutations in cleidocranial dysplasia.
    Lee KE; Seymen F; Ko J; Yildirim M; Tuna EB; Gencay K; Kim JW
    Genet Mol Res; 2013 Oct; 12(4):4567-74. PubMed ID: 24222232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cbfa1: a molecular switch in osteoblast biology.
    Ducy P
    Dev Dyn; 2000 Dec; 219(4):461-71. PubMed ID: 11084646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
    Xiao ZS; Hinson TK; Quarles LD
    J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel frameshift mutation (383insT) in the RUNX2 (PEBP2 alpha/CBFA1/AML3) gene in a Japanese patient with cleidocranial dysplasia.
    Goseki-Sone M; Orimo H; Watanabe A; Hamatani R; Yokozeki M; Ohyama K; Kuroda T; Watanabe H; Miyazaki H; Shimada T; Oida S
    J Bone Miner Metab; 2001; 19(4):263-6. PubMed ID: 11448020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel missense mutation of the CBFA1 gene in a family with cleidocranial dysplasia (CCD) and variable expressivity.
    Golan I; Preising M; Wagener H; Baumert U; Niederdellmann H; Lorenz B; Müssig D
    J Craniofac Genet Dev Biol; 2000; 20(3):113-20. PubMed ID: 11321595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleidocranial dysplasia and RUNX2-clinical phenotype-genotype correlation.
    Jaruga A; Hordyjewska E; Kandzierski G; Tylzanowski P
    Clin Genet; 2016 Nov; 90(5):393-402. PubMed ID: 27272193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo.
    Zheng H; Guo Z; Ma Q; Jia H; Dang G
    Calcif Tissue Int; 2004 Feb; 74(2):194-203. PubMed ID: 14595529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CBFA1/PEBP2 alpha A].
    Komori T
    Nihon Rinsho; 1998 Jun; 56(6):1430-4. PubMed ID: 9648460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function.
    Geoffroy V; Corral DA; Zhou L; Lee B; Karsenty G
    Mamm Genome; 1998 Jan; 9(1):54-7. PubMed ID: 9434946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of Cleidocranial Dysplasia with a Novel Mutation and Growth Velocity Gain with Growth Hormone Treatment.
    Çamtosun E; Akıncı A; Demiral E; Tekedereli İ; Sığırcı A
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):301-305. PubMed ID: 30468148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells.
    Tsuji K; Noda M
    J Bone Miner Metab; 2001; 19(4):213-9. PubMed ID: 11448013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleidocranial dysplasia with decreased bone density and biochemical findings of hypophosphatasia.
    Morava E; Kárteszi J; Weisenbach J; Caliebe A; Mundlos S; Méhes K
    Eur J Pediatr; 2002 Nov; 161(11):619-22. PubMed ID: 12424590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of intrafamilial variability of CBFA1/RUNX2 expression in cleidocranial dysplasia--a family study.
    Golan I; Baumert U; Wagener H; Preising M; Lorenz B; Niederdellmann H; Müssig D
    J Orofac Orthop; 2002 May; 63(3):190-8. PubMed ID: 12132307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal diagnosis of a cleidocranial dysplasia-like phenotype associated with a de novo balanced t(2q;6q)(q36;q16) translocation.
    Winer N; Le Caignec C; Quere MP; David A; Boceno M; Aubron F; Joubert M; Boog G; Philippe HJ; Rival JM
    Ultrasound Obstet Gynecol; 2003 Dec; 22(6):648-51. PubMed ID: 14689542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tooth eruption and cementum formation in the Runx2/Cbfa1 heterozygous mouse.
    Zou SJ; D'Souza RN; Ahlberg T; Bronckers AL
    Arch Oral Biol; 2003 Sep; 48(9):673-7. PubMed ID: 12888002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor.
    Xiao G; Wang D; Benson MD; Karsenty G; Franceschi RT
    J Biol Chem; 1998 Dec; 273(49):32988-94. PubMed ID: 9830051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cDNA cloning of the transcripts of human PEBP2alphaA/CBFA1 mapped to 6p12.3-p21.1, the locus for cleidocranial dysplasia.
    Zhang YW; Bae SC; Takahashi E; Ito Y
    Oncogene; 1997 Jul; 15(3):367-71. PubMed ID: 9233771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Holoprosencephaly and cleidocranial dysplasia in a patient due to two position-effect mutations: case report and review of the literature.
    Fernandez BA; Siegel-Bartelt J; Herbrick JA; Teshima I; Scherer SW
    Clin Genet; 2005 Oct; 68(4):349-59. PubMed ID: 16143022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.